Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer
PROTOCOL FOR THE SCOTTISH PREMENOPAUSAL CHEMO-ENDOCRINE TRIAL
Sponsor: Scottish Cancer Therapy Network
This PHASE3 trial investigates Breast Cancer and is currently completed. Scottish Cancer Therapy Network leads this study, which shows 5 recorded versions since 1993 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Jun 1993
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Scottish Cancer Therapy Network
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Aberdeen, United Kingdom
- • Ayr, United Kingdom
- • Dundee, United Kingdom
- • Edinburgh, United Kingdom
- • Falkirk, United Kingdom
- • Glasgow, United Kingdom
- • Inverness, United Kingdom
- • Leicester, United Kingdom
- • Paisley, United Kingdom